A Double-Blind, Randomized, Placebo-Controlled, Safety, Tolerability, and Efficacy Trial of a Novel Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For The Treatment of Atopic Dermatitis
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2017
At a glance
- Drugs Santalum album (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Santalis Pharmaceuticals
- 24 Oct 2017 Protocol was amended to change in the treatment arms and change in status from active no longer recruiting to recruiting of the trial .
- 24 Oct 2017 Planned End Date changed from 1 Feb 2018 to 1 Mar 2018.
- 24 Oct 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Feb 2018.